Berrak S G, Angaji M, Turkkan E, Canpolat C, Timur C, Eksioglu-Demiralp E
Pediatric Hematology Oncology, Marmara Medical Faculty, Altunizade, Istanbul, Turkey.
Cell Prolif. 2007 Oct;40(5):741-54. doi: 10.1111/j.1365-2184.2007.00460.x.
Iron is essential for DNA synthesis; its deficiency may lead to impaired DNA synthesis and subsequent alterations in levels of apoptosis. Here, we have aimed to investigate effects of iron deficiency anaemia (IDA) on apoptotic response of phagocytic cells and to understand whether the effect is reversible after iron supplementation.
Forty-nine IDA patients and 26 healthy controls, aged between 6 months and 12 years with similar demographic status, were considered. Neutrophil- and monocyte-apoptotic responses of IDA patients and the control group were compared by flow cytometry. Then, IDA patients were provided with oral iron supplementation. On day 15 of iron therapy, neutrophil- and monocyte-apoptotic responses of IDA patients were rechecked and were compared to those of control group.
Neutrophil- and monocyte-apoptotic responses in terms of early and late percentages of apoptosis, and percentages of necrotic cells, were significantly less in IDA patients compared to the control group. The significantly low apoptotic responses of IDA patients rose to levels of the control group by day 15 of iron therapy. Besides, the effect of IDA on apoptotic responses was found to be more enhanced in severe IDA patients that those of mild IDA patients.
Correction of differences after iron supplementation therapy implies that IDA might be a cause for changes in neutophil- and monocyte-apoptotic responses. The impact of this diminution of apoptotic cellular function in IDA should be further investigated, with longitudinal studies, in order to document the impact of any severe and/or long-lasting IDA on autoimmunity and malignancy.
铁对于DNA合成至关重要;铁缺乏可能导致DNA合成受损以及随后细胞凋亡水平的改变。在此,我们旨在研究缺铁性贫血(IDA)对吞噬细胞凋亡反应的影响,并了解补铁后这种影响是否可逆。
纳入49例IDA患者和26例健康对照,年龄在6个月至12岁之间,人口统计学特征相似。通过流式细胞术比较IDA患者和对照组中性粒细胞及单核细胞的凋亡反应。然后,给予IDA患者口服补铁治疗。在补铁治疗第15天,复查IDA患者中性粒细胞及单核细胞的凋亡反应,并与对照组进行比较。
与对照组相比,IDA患者在早期和晚期凋亡百分比以及坏死细胞百分比方面的中性粒细胞和单核细胞凋亡反应显著降低。在补铁治疗第15天时,IDA患者显著较低的凋亡反应上升至对照组水平。此外,发现严重IDA患者中IDA对凋亡反应的影响比轻度IDA患者更为明显。
补铁治疗后差异得到纠正,这意味着IDA可能是中性粒细胞和单核细胞凋亡反应改变的一个原因。为了记录任何严重和/或长期IDA对自身免疫和恶性肿瘤的影响,应通过纵向研究进一步调查IDA中这种细胞凋亡功能减弱的影响。